Zobrazeno 1 - 5
of 5
pro vyhledávání: '"H O J, Peels"'
Autor:
M, de Mulder, C J M, Broers, E K, Jansen, H B R M, de Swart, H O J, Peels, M L M, Lieuw-A-Fa, V A W M, Umans
Publikováno v:
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 18(1)
Background. The current treatment of choice in patients with three-vessel coronary disease is coronary artery bypass grafting. The use of the left internal mammary artery in bypass grafting has shown superior long-term outcomes compared with venous g
Autor:
T. Baardman, J. Stibbe, H. Suryapranata, M. van den Brand, J.W. Deckers, L. R. van der Wieken, C. van der Zwaan, H O J Peels, K.M. Akkerhuis, M. L. Simoons, J. Hoffmann
Publikováno v:
Heart, 85, 444-450. BMJ Publishing Group
OBJECTIVE—Lefradafiban is the orally active prodrug of fradafiban, a glycoprotein IIb/IIIa receptor antagonist. The present phase II study aimed to determine the dose of lefradafiban that provides 80% blockade of the glycoprotein IIb/IIIa receptors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7dd4f3ec79b0ffb12915b44ca1aefca
https://pure.eur.nl/en/publications/773e581d-3dae-4fc3-be61-93a21a5da454
https://pure.eur.nl/en/publications/773e581d-3dae-4fc3-be61-93a21a5da454
Autor:
Protti, Ícaro F., Rodrigues, Daniel R., Fonseca, Sofia K., Alves, Ricardo J., Oliveira, Renata B., Maltarollo, Vinícius G.
Publikováno v:
ChemMedChem; 5/6/2021, Vol. 16 Issue 9, p1446-1456, 11p
Publikováno v:
Surface Review & Letters; Jan2017, Vol. 24 Issue 1, p-1, 14p
Autor:
Akkerhuis, K.M., van den Brand, M.J.B.M., van der Zwaan, C., Peels, H.O.J., Suryapranata, H., van der Wieken, L.R., Stibbe, J., Hoffmann, J., Baardman, T., Deckers, J.W., Simoons, M.L.
Publikováno v:
Heart; Apr2001, Vol. 85 Issue 4, p444, 7p